A Phase 1, Open-Label, Multicenter, Dose-Escalation Study to Evaluate the Safety and Tolerability of SHR-1316 in Subjects with Advanced Solid Tumors

  • Markman, Ben (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date28/02/19 → 27/02/24